Trade Radius Health Inc - RDUS

RDUS

Radius (RDUS) is a biopharmaceutical company engaged in innovative development, with a special focus on oncology, osteoporosis and endocrine diseases. The company was founded in 2003. With offices in Waltham, Cambridge, Parsippany, Massachusetts, New Jersey and Wayne, Radius is now engaged in developing a selective estrogen receptor degrader called RAD1901. Also, the company works on RAD140, an investigational selective androgen receptor modulator drug. Radius Health is traded on the NASDAQ stock exchange and the company is headquartered in Waltham, USA.

You might be interested in

NDX1

Nordex SE

14.715

0.360

ADBE

Adobe Systems Inc

277.42

4.86

FTCH

Farfetch Ltd

24.51

0.96

WDAY

Workday Inc

194.80

5.00

A world first

Our advanced web platform is the world’s first regulated tokenised securities exchange.

Crypto as collateral

Trade the global financial markets using Bitcoin or Ethereum.

Security as priority

Authorised by the High Technology Park of Belarus, the European blockchain regulator, the safety of your holdings is guaranteed.

Technical indicators

Keep an eye on your positions with over 75 advanced charts, price analysis and price alerts.

Control your capital

Use stop-loss and take-profit orders to keep what you earn.

Use the world’s first regulated tokenised securities exchange to build a diverse investment portfolio with your crypto holdings. Make your deposits in Bitcoin or Ethereum to trade global financial instruments with competitive leverage and tight spreads. Currency.com keeps your holdings secure and accessible at a glance.